Ronghua Zhao

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine

Fei Liu, W. Jia, Xiaoming Yang, 2022, bioRxiv.

Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus

I. Samudio, W. Jia, I-Fang Lee, 2022, Viruses.

Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy

Chenfang Dong, Qiao-yun Leng, Chaomei Zhang, 2023, Journal of medical virology.

VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes

Yu Lou, Xiaozhen Zhang, T. Liang, 2022, Journal of medical virology.

Initial results from a first in human trial incorporating accelerated dose titration of a novel immune stimulating oncolytic virus - VG161.

W. Jia, N. Aggarwal, A. Joshua, 2021 .

Novel mRNA vaccines encoding Monkeypox virus M1R and A35R protect mice from a lethal virus challenge

W. Jia, Yingying Song, Xiaoming Yang, 2022, bioRxiv.